A group of medical researchers has issued a warning after linking cases of unprovoked venous thrombosis in healthy people to Covid mRNA “vaccines.”

Researchers at Qatar University‘s Hamad Medical Corporation and Weill Cornell Medicine launched an investigation after individuals without conventional risk factors began suffering from deadly thrombotic events.

The researchers sought to determine whether Covid “vaccines” were linked to the rise which started after the injections were rolled out for public use.

Their study takes a retrospective approach to evaluating venous thromboembolism (VTE).

VTE is a condition that occurs when a blood clot forms in a vein and it includes deep vein thrombosis (DVT) and pulmonary embolism (PE).

DVT occurs when a blood clot forms in deep veins, usually in the lower leg, thigh, or pelvis.

If there is a large intravenous central line in the vein, DVTs can also occur in the arms.

Pulmonary embolism occurs when a clot breaks loose and travels through the bloodstream to the lungs.

The results of the study were published in the Ibnosina Journal of Medicine and Biomedical Sciences.

This retrospective case series analyzed seven individuals who developed unprovoked VTE after receiving Covid mRNA “vaccines.”

The patients were drawn from the anticoagulation clinic at Hamad General Hospital in Doha, one of the largest tertiary care centers in Qatar.

The study examined:

• Demographic and clinical characteristics

• Timing of thrombotic events relative to vaccination

• Thrombophilia screening and other diagnostic workups

• Management and treatment outcomes

All cases were categorized as unprovoked VTE, meaning the affected individuals lacked identifiable risk factors such as recent surgery, prolonged immobilization, hormone therapy, malignancy, or inherited thrombophilia.

Of the seven cases analyzed, five involved dangerous deep vein thrombosis (DVT), four of which progressed to a deadly pulmonary embolism (PE).

One patient developed portal vein thrombosis (PVT)—an exceedingly rare event outside of underlying liver disease or cancer.

• Case 1: A 34-year-old woman presented with DVT and PE 20 days post-Pfizer vaccination.

• Case 2: A 29-year-old man developed superficial vein thrombosis three months post-Moderna vaccine, with no underlying pathology detected.

• Case 3: A 36-year-old man with Klinefelter’s syndrome developed bilateral PE and DVT one month after receiving the Pfizer vaccine.

• Case 4: A 39-year-old man developed DVT in the upper arm (subclavian, axillary, and brachial veins) two weeks post-Moderna vaccine.

• Case 5: A 42-year-old woman developed femoral DVT five days after receiving her second Pfizer dose.

• Case 6: A 57-year-old man with hypertension and diabetes developed bilateral PE and DVT 10 days post-Moderna vaccination.

• Case 7: A 39-year-old man presented with portal vein thrombosis (PVT) three weeks post-Pfizer vaccination, despite no prior liver disease or hypercoagulable disorder.

The unifying characteristic across all cases was the absence of conventional risk factors for thrombosis, making these events particularly concerning.

The case series adds to the growing body of literature reporting thrombotic events post-mRNA vaccination.

Unlike vaccine-induced immune thrombotic thrombocytopenia (VITT), which has been primarily linked to adenovirus-based vaccines such as AstraZeneca’s ChAdOx1 nCoV-19, these cases occurred following mRNA “vaccine” administration without accompanying thrombocytopenia.

The researchers explain that the mRNA “vaccines” instruct the body to produce spike proteins, which have been implicated in triggering inflammatory and prothrombotic pathways.

They also note that vaccine-induced immune responses could initiate thrombotic pathways in some individuals.

This study raises important concerns regarding post-mRNA “vaccine” thrombotic events in otherwise healthy individuals.

Given that millions worldwide have received these vaccines, even a rare event could translate into a significant number of affected individuals.

In such numbers, these “rare but real” adverse events mean hundreds of thousands to millions worldwide may experience problems.

Source: https://slaynews.com/news/warning-issued-covid-vaccines-linked-venous-thrombosis-healthy-people/

Bitchute: https://www.bitchut,e.com/channel/YBM3rvf5ydDM/

Gab: https://gab.com/hopegirl

Telegram: https://t.me/Hopegirl587

EMF Protection Products: www.ftwproject.com

QEG Clean Energy Academy: www.cleanenergyacademy.com

Forbidden Tech Book: www.forbiddentech.website

The post Warning Issued as Covid ‘Vaccines’ Linked to Venous Thrombosis in Healthy People appeared first on HopeGirl Blog.